eczema market - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

France protests trigger 1,800 arrests as Macron faces nationwide crisis

Editorial infographic showing humanoid and industrial robots in a warehouse, with digital-twin mapping and key figures on commissioning, picking accuracy, operating hours and robotics orders.

Can physical AI escape the demo stage and become real industrial infrastructure?

Modal Labs has secured $750 million in Series D funding at a $15.75 billion valuation, marking a nearly 239% valuation surge in five months as demand for AI inference, GPU cloud infrastructure and autonomous coding agents accelerates, pushing the company's annualized run rate beyond $1 billion. Representative image.

Modal valuation jumps 239% as AI infrastructure demand drives $750m Series D

Salad and Go is coming back after bankruptcy, but competitors bought most of its old drive-thru network

Read More

Pharma Industry News

Why Arcutis Biotherapeutics, Inc. is targeting infant eczema with ZORYVE cream

Can ZORYVE cream unlock infant eczema markets? Discover how Arcutis Biotherapeutics, Inc. is reshaping dermatology strategy today.

bySoujanya Ravi

April 30, 2026

web analytics